SB-406725A

N/A

Report date: 2022/03/24 10:20:57

Base Information

Drug NameSB-406725A
Drug Alias NameSB-406725A406725-A362115362115-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGap junction proteins inhibitors
TargetsGap junction proteins
Therapy Area/IndicationsNeuralgiaMigraine DisordersEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsNeuralgiaMigraine DisordersEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A